POST Online Media Lite Edition



 

Agilent Technologies Q4 GAAP net income $16 million

Staff writer |
Agilent Technologies reported orders of $1.91 billion, up 4 percent over one year ago, for the fourth fiscal quarter ended October 31, 2014, and revenues of $1.81 billion, up 5 percent compared with one year ago.




Fourth-quarter GAAP net income was $16 million, or $0.05 per share. Last year's fourth-quarter GAAP net income was $211 million, or $0.63 per share.

These results include Keysight Technologies, formerly Agilent's electronic measurement business. Agilent completed the spinoff of Keysight on Nov. 1 by distributing Keysight common stock to Agilent shareholders. Keysight financial results will be reported by Keysight as a separate, publicly traded company.

During the fourth quarter, Agilent had pre-separation costs of $70 million, intangible amortization of $47 million, a net loss on extinguishment of debt of $68 million, mostly non-cash charges of $68 million related to exiting the Nuclear Magnetic Resonance business, and a tax expense of $13 million. Excluding these items and $15 million of other net costs, Agilent reported fourth-quarter adjusted net income of $297 million, or $0.88 per share.

Agilent's Life Sciences, Diagnostics and Applied Chemical Markets (LDA) revenues were $1.04 billion, up 3 percent over last year, reflecting growth across all key end markets. Orders of $1.15 billion were up 5 percent compared with last year. LDA operating margin was 20.4 percent.

Agilent Technologies Inc. (NYSE: A) today reported orders of $1.91 billion, up 4 percent over one year ago, for the fourth fiscal quarter ended Oct. 31, 2014, and revenues of $1.81 billion, up 5 percent compared with one year ago. Fourth-quarter GAAP net income was $16 million, or $0.05 per share. Last year's fourth-quarter GAAP net income was $211 million, or $0.63 per share.

These results include Keysight Technologies, formerly Agilent's electronic measurement business. Agilent completed the spinoff of Keysight on Nov. 1 by distributing Keysight common stock to Agilent shareholders. Keysight financial results will be reported by Keysight as a separate, publicly traded company.

During the fourth quarter, Agilent had pre-separation costs of $70 million, intangible amortization of $47 million, a net loss on extinguishment of debt of $68 million, mostly non-cash charges of $68 million related to exiting the Nuclear Magnetic Resonance business, and a tax expense of $13 million. Excluding these items and $15 million of other net costs, Agilent reported fourth-quarter adjusted net income of $297 million, or $0.88 per share.

Agilent's Life Sciences, Diagnostics and Applied Chemical Markets (LDA) revenues were $1.04 billion, up 3 percent over last year, reflecting growth across all key end markets. Orders of $1.15 billion were up 5 percent compared with last year. LDA operating margin was 20.4 percent.


What to read next

Agilent Technologies Q4 revenue up 7.1 percent
Agilent Technologies Q2 revenue $1.10 billion
Agilent Technologies Q2 revenue up 6 percent